Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lichter

Showing results (271-280 of 339) with videos related to

Pageof 34
Sort By:
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
Nature Medicine|August 7, 2015
Toward understanding and exploiting tumor heterogeneityAsh A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Report: workshop on mediastinal grey zone lymphomaSibrand Poppema, Joost L Kluiver, Cigdem Atayar, et al.
Nature Medicine|October 24, 2018
A biobank of patient-derived pediatric brain tumor modelsSebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDH<sup>mut</sup>-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Pageof 34

Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
Nature Medicine|August 7, 2015
Toward understanding and exploiting tumor heterogeneityAsh A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Report: workshop on mediastinal grey zone lymphomaSibrand Poppema, Joost L Kluiver, Cigdem Atayar, et al.
Nature Medicine|October 24, 2018
A biobank of patient-derived pediatric brain tumor modelsSebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDH<sup>mut</sup>-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Pageof 34